---

Sue Desmond

Hellmann Chief Executive Officer, Bill & Melinda Gates Foundation

After training as an oncologist, Sue spent 14 years as head of product development at Genentech – where she played a role in the development of Herceptin and Avastin. Next, she spent five years as the first female Chancellor of the University of California, San Francisco. As the first physician and research scientist CEO of the Bill & Melinda Gates Foundation, she draws on her public and private sector experience to combat infectious disease and empower people – especially women and girls.

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018